120 completed, 41 recruiting, 31 unknown, 24 terminated. 87 Phase 2, 53 Phase 1, 46 Not applicable, 30 Phase 3, 2 Early Phase 1.
Follow Peritoneal Neoplasms: new trials by email Literature Review of Peritoneal Neoplasms trials Research Report on Peritoneal Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) GEH300079 (68Ga) Injection Positron-Emission Tomography (PET)/Computed Tomography (CT) - Colorectal Cancer, Gastric Cancers | Phase 2 / Phase 3 | Recruiting | GE Healthcare | 175 | 2026-10-01 | 2026-06-17 |
| Paricalcitol Versus Pirfenidone for Improving Surgical Resectability in Patients With Peritoneal Cancer Paricalcitol, pirfenidone - Peritoneal (Metastatic) Cancer, Peritoneal Carcinoma | Phase 2 | Not yet recruiting | Patrick Wagner, MD, FACS | 74 | 2026-09-01 | 2026-10-05 |
| TLR9 Immunotherapy for Peritoneal Carcinomatosis ACM-CpG - Malignant Ascites, Colorectal Adenocarcinoma | Phase 1 | Recruiting | Brown University | 24 | 2026-08-25 | 2026-10-01 |
| Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors Mitomycin C (MMC), Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) - Peritoneal Carcinomatosis | Phase 1 | Recruiting | H. Lee Moffitt Cancer Center and Research Institute | 24 | 2026-08-05 | 2026-09-16 |
| Remimazolam Versus Propofol for Early Recovery After Cytoreductive Surgery Remimazolam, Propofol - Peritoneal Neoplasms, Postoperative Recovery | Not applicable | Not yet recruiting | Beijing Tsinghua Chang Gung Hospital | 320 | 2026-08-01 | 2026-08-25 |
| MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial). MRI-guided stereotactic body radiotherapy - Peritoneal Carcinomatosis, Oligometastatic Disease | Phase 2 | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 34 | 2026-07-01 | 2026-05-18 |
| Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) Modified early post-operative intraperitoneal chemotherapy (mEPIC) - Peritoneal Carcinomatosis, Appendiceal Neoplasms | Phase 2 | Recruiting | Ciusss de L'Est de l'Île de Montréal | 25 | 2026-05-01 | 2026-05-14 |
| To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement. Pancreatectomy, Complete Cytoreduction, Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - Pancreatic Adenocarcinoma, Peritoneal (Metastatic) Cancer | Not applicable | Recruiting | Unidade Local de Saúde São João, Oporto | 20 | 2026-03-01 | 2026-03-25 |
| The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry Appendix Cancer, Pseudomyxoma Peritonei | Recruiting | Appendix Cancer Pseudomyxoma Peritonei Research Foundation | 10000 | 2026-02-02 | 2026-08-17 | |
| Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management. Ventral Hernias, Cytoreductive Surgery | Recruiting | Jules Bordet Institute | 500 | 2026-01-20 | 2026-03-05 | |
| Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining) Heated intra-peritoneal chemotherapy, Aerosolized intra-peritoneal chemotherapy - Peritoneal (Metastatic) Cancer, Peritoneal Carcinomatosis | Phase 2 | Recruiting | Patrick Wagner, MD, FACS | 200 | 2026-01-05 | 2026-02-27 |
| Prophylactic PIPAC in Patients With High-risk Colorectal Cancer oxaliplatin-based PIPAC, Control (Standard treatment) - Colorectal Cancer Control and Prevention, Colorectal Cancer | Phase 3 | Not yet recruiting | Jeremy Meyer | 160 | 2026-01-01 | 2025-07-30 |
| Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer Pressurized intraperitoneal aerosol chemotherapy (PIPAC) using paclitaxel - Ovarian Neoplasms, Peritoneal Neoplasms | Phase 1 / Phase 2 | Not yet recruiting | Seoul National University Hospital | 53 | 2026-01-01 | 2025-12-09 |
| Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis Paclitaxel, NALIRIFOX - Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 1 | Recruiting | University of Colorado, Denver | 10 | 2025-12-31 | 2026-02-02 |
| Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity Standard of Care Chemotherapy, Biospecimen Collection, Computed Tomography - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 / Phase 3 | Recruiting | ECOG-ACRIN Cancer Research Group | 148 | 2025-10-24 | 2026-10-05 |
| A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer Sofetabart Mipitecan, Paclitaxel, Topotecan - Ovarian Neoplasms, Fallopian Tube Neoplasms | Phase 3 | Recruiting | Eli Lilly and Company | 1630 | 2025-10-22 | 2026-10-08 |
| SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery High-Purity Type-I Collagen Scaffold, Standard Peritonectomy Closure - Peritoneal Surface Malignancy, Postoperative Adhesion | Not applicable | Completed | Adichunchanagiri Institute of Medical Sciences, B G Nagara | 60 | 2025-10-20 | 2026-03-30 |
| Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer Cisplatin, Mitomycin - Gastric Cancer, Peritoneal Carcinomatosis | Phase 2 | Recruiting | University of Chicago | 21 | 2025-09-09 | 2026-09-08 |
| Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy Intra-operative albumin administration, Control - Peritoneal Neoplasms, Hyperthermic Intraperitoneal Chemotherapy | Not applicable | Recruiting | Assistance Publique - Hôpitaux de Paris | 140 | 2025-09-03 | 2026-09-29 |
| Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer. Blood sampling - Peritoneal Carcinomatosis, Peritoneal Metastases From Colorectal Cancer | Not applicable | Recruiting | Hospices Civils de Lyon | 58 | 2025-05-06 | 2026-02-13 |
Showing 20 of 242. Sign in to see all of them.
Ovarian Neoplasms (86) · Fallopian Tube Neoplasms (52) · Colorectal Neoplasms (42) · Stomach Neoplasms (41) · Neoplasms (20) · Carcinoma, Ovarian Epithelial (17) · Colonic Neoplasms (17) · Appendiceal Neoplasms (14) · Pancreatic Neoplasms (14) · Carcinoma (13) · Neoplasm Metastasis (13) · Pseudomyxoma Peritonei (10) · Recurrence (8) · Adenocarcinoma (7)
Digestive System Diseases (242) · Neoplasms by Site (241) · Digestive System Neoplasms (240) · Abdominal Neoplasms (239) · Peritoneal Diseases (239) · Neoplasms (222) · Endocrine Gland Neoplasms (98) · Endocrine System Diseases (98) · Gastrointestinal Diseases (96) · Adnexal Diseases (92) · Female Urogenital Diseases (92) · Female Urogenital Diseases and Pregnancy Complications (92) · Genital Diseases (92) · Urogenital Diseases (92) · Gonadal Disorders (91)
Hyperthermic Intraperitoneal Chemotherapy (28) · Paclitaxel (24) · Cisplatin (23) · Oxaliplatin (18) · Carboplatin (17) · Cytoreduction Surgical Procedures (17) · Fluorouracil (14) · Bevacizumab (10) · Doxorubicin (9) · Leucovorin (9) · Mitomycin (9) · Docetaxel (6) · 130-nm albumin-bound paclitaxel (5) · Gemcitabine (5) · Albumin-Bound Paclitaxel (4)
National Cancer Institute (NCI) (13) · Hospices Civils de Lyon (8) · University Hospital, Ghent (7) · M.D. Anderson Cancer Center (6) · Eli Lilly and Company (5) · Institut du Cancer de Montpellier - Val d'Aurelle (5) · Jules Bordet Institute (5) · Hoffmann-La Roche (4) · AGO Study Group (3) · Laval University (3) · Michael Bau Mortensen (3) · Novartis Pharmaceuticals (3) · Oslo University Hospital (3) · The Netherlands Cancer Institute (3) · University of California, Irvine (3)
United States (89) · France (38) · Belgium (30) · Germany (26) · Spain (22) · China (17) · Italy (17) · Canada (16) · Netherlands (14) · Denmark (11) · Poland (11) · United Kingdom (11) · Australia (10) · South Korea (10) · Norway (9)
Alexandre Brind'Amour, MD (3) · Andrea Hayes-Jordan, MD (2) · Andrew M Blakely, M.D. (2) · Brian D Badgwell (2) · Elise C Kohn, M.D. (2) · Gabriel Liberale, MD (2) · Kjersti Flatmark, MD PhD (2) · Maheswari Senthil, MD (2) · Patrick Wagner, MD (2) · Wim P Ceelen, MD, PhD (2)
PMID 37407274, PMID 37185961, PMID 11547741, PMID 11762804, PMID 14745444, PMID 16452199, PMID 16790085, PMID 17708508, PMID 19181369, PMID 19942597, PMID 20008305, PMID 20068097, PMID 20500867, PMID 20525328, PMID 21160814, PMID 21424369, PMID 21733566, PMID 21990299, PMID 22274685, PMID 22987083, PMID 23109694, PMID 23377563, PMID 23474348, PMID 23765417, PMID 24006094, PMID 24071502, PMID 24275155, PMID 24318743, PMID 24447964, PMID 24756812, PMID 25254563, PMID 26003804, PMID 26590673, PMID 26669784, PMID 26673788, PMID 26681640, PMID 26742998, PMID 27520560, PMID 27633880, PMID 28501086, PMID 28529748, PMID 29149865, PMID 29413875, PMID 29773661, PMID 29899763, PMID 30131226, PMID 30185117, PMID 30197280, PMID 30463745, PMID 30473706
2019 (4), 2009 (3), 2016 (3), 2018 (3), 2005 (1), 2008 (1), 2014 (1), 2015 (1), 2017 (1), 2023 (1), 2025 (1), P01CA132714 (1), P30CA006973 (1), P30CA013330 (1), P30CA033572 (1)